Conference Dates
June 12 – 17, 2022
Abstract
Vaccine development requires accurate scale down models that can provide both qualitative and quantitative data that can be utilized for process development. With such data, time to pilot scale can be minimized and provide cost and time savings.
Please click Download on the upper right corner to see the full abstract.
Please click Additional File below for the presentation.
Recommended Citation
Jessica Olson, Greeshma Manomohan, Alyssa Brown, Christopher Lee, Samantha Moyer, and Marc Wenger, "AMBR®250 HT System: A key process development tool for new live virus and microbial vaccine candidates" in "Vaccine Technology VIII", Tarit Mukhopadhyay, Merck Research Laboratories, USA; Charles Lutsch, Sanofi Pasteur, France; Linda Hwee-Lin Lua, University of Queensland, Australia; Francesc Godia, Universitat Autònoma de Barcelona, Spain Eds, ECI Symposium Series, (2022). https://dc.engconfintl.org/vaccine_viii/21